Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Change in Taxes (2020 - 2021)

Nurix Therapeutics (NRIX) has disclosed Change in Taxes for 2 consecutive years, with -$2.9 million as the latest value for Q3 2021.

  • On a quarterly basis, Change in Taxes rose 81.33% to -$2.9 million in Q3 2021 year-over-year; TTM through Nov 2021 was -$3.6 million, a N/A change, with the full-year FY2021 number at -$3.6 million, down 194.7% from a year prior.
  • Change in Taxes was -$2.9 million for Q3 2021 at Nurix Therapeutics, down from -$839000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $135000.0 in Q1 2021 to a low of -$15.7 million in Q3 2020.